Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.05 -0.08 (-1.94%)
At close: Oct 23, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Cash & Current Investments (2013 - 2025)

Updated

Corbus Pharmaceuticals Holdings (CRBP) posted Cash & Current Investments of $163.27 million for Q4 2025, up 9.5% from $149.06 million a year earlier and up 57.0% from the prior quarter.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Cash & Current Investments (2013 - 2025) Analysis & Trends

Since Q3 2013, Corbus Pharmaceuticals Holdings has reported Cash & Current Investments for 50 quarters.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 13.8% (FY2020 to FY2025).
  • In prior years, Corbus Pharmaceuticals Holdings' Cash & Current Investments was $149.06 million in FY2024 (+613.0%), $20.91 million in FY2023 (-64.7%), $59.2 million in FY2022 (-39.4%) and $97.65 million in FY2021 (+14.3%).
  • The Q4 2025 figure stands as the highest quarterly Cash & Current Investments in data going back to Q3 2013.
  • On a year-over-year basis, Cash & Current Investments increased in six of the last eight quarters, with growth averaging 188.2%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2024, with growth of 613.0%; the weakest was Q4 2023, with a decline of 64.7%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $103.98 million (Q3 2025), $116.59 million (Q2 2025) and $132.79 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Corbus Pharmaceuticals Holdings 49.84 Mn -466.79 Mn - 163.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 163.27 Mn
Sep 30, 2025 103.98 Mn
Jun 30, 2025 116.59 Mn
Mar 31, 2025 132.79 Mn
Dec 31, 2024 149.06 Mn
Sep 30, 2024 159.36 Mn
Jun 30, 2024 147.03 Mn
Mar 31, 2024 120.10 Mn
Dec 31, 2023 20.91 Mn
Sep 30, 2023 28.73 Mn
Jun 30, 2023 36.57 Mn
Mar 31, 2023 44.23 Mn
Dec 31, 2022 59.20 Mn
Sep 30, 2022 66.23 Mn
Jun 30, 2022 73.30 Mn
Mar 31, 2022 86.12 Mn
Dec 31, 2021 97.65 Mn
Sep 30, 2021 106.86 Mn
Jun 30, 2021 106.45 Mn
Mar 31, 2021 124.01 Mn
API Access

Corbus Pharmaceuticals Holdings Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CRBP&period=max&api_key=YOUR_API_KEY